New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination

The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and s...

Full description

Saved in:
Bibliographic Details
Published inClinical case reports Vol. 9; no. 9; pp. e04865 - n/a
Main Authors Kaminetsky, Joshua, Rudikoff, Donald
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.09.2021
John Wiley and Sons Inc
Wiley
Subjects
adverse reaction
Case Report
Case reports
Conflicts of interest
Consent
Coronaviruses
COVID-19 vaccines
COVID‐19
mRNA vaccine
Patients
Vitiligo
vitiligo
COVID‐19
adverse reaction
mRNA vaccine
Online AccessGet full text

Cover

More Information
Summary:The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients. The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.
Bibliography:Funding information
No external funding source was utilized in the production of this manuscript.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.4865